JAY BIRNBAUM - Corporate Board Profile

Sonoma Pharmaceuticals, Inc.

Filing Date	Source Excerpt
2007-08-17	He received both an M.S. and Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.
2008-07-21	Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.
2009-07-29	Dr. Birnbaum is a pharmacologist and, prior to his current role as a consultant to pharmaceutical companies, he served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals Corporation.
2010-07-29	He received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.
2011-07-29	Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.
2012-07-27	Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.
2013-02-05	Jay Birnbaum (9) Director
2013-07-29	Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.
2014-07-29	Dr. Birnbaum is a pharmacologist... Education: B.S. in Biology from Trinity College in Connecticut, Ph.D. in Pharmacology from the University of Wisconsin... Special Knowledge, Skills, and Abilities: Extensive Knowledge of the Company’s Business, Pharmaceutical Background, Leadership.
2014-11-07	Dr. Birnbaum is a member of our Board of Directors.
2015-06-08	Dr. Birnbaum is a member of our Board of Directors. He beneficially owns 0 shares of common stock and 158,025 shares of common stock issuable upon the exercise of options that are exercisable within 60 days of May 21, 2015.
2015-07-28	Dr. Birnbaum is a pharmacologist... Education: B.S. in Biology, Ph.D. in Pharmacology. Special Knowledge, Skills, and Abilities: Extensive Knowledge of the Company’s Business, Pharmaceutical Background, Leadership.
2016-07-29	Dr. Birnbaum is a pharmacologist... Education: B.S. in Biology, Ph.D. in Pharmacology... Special Knowledge, Skills, and Abilities: Extensive Knowledge of the Company’s Business, Pharmaceutical Background, Leadership.
2017-07-27	Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies in his area of expertise. He previously served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals Corporation, where he was responsible for the strategic planning and development of the company’s dermatology portfolio.
2018-07-27	Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies... Education: B.S. in Biology from Trinity College in Connecticut, Ph.D. in Pharmacology from the University of Wisconsin.
2019-04-22	Jay Birnbaum (8) Director
2019-07-29	Education: B.S. in Biology from Trinity College; Ph.D. in Pharmacology from the University of Wisconsin; Special Knowledge, Skills, and Abilities: Extensive Knowledge of the Company’s Business, Pharmaceutical Background, Leadership.
2020-07-29	Education: B.S. in Biology from Trinity College in Connecticut, Ph.D. in Pharmacology from the University of Wisconsin. Special Knowledge, Skills, and Abilities: Extensive Knowledge of the Company’s Business, Pharmaceutical Background, Leadership.
2021-07-29	B.S. in Biology from Trinity College; Ph.D. in Pharmacology from the University of Wisconsin; extensive pharmaceutical industry experience.
2022-07-22	Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies in his area of expertise. He previously served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals Corporation, where he was also responsible for the strategic planning and development of the company’s dermatology portfolio. Dr. Birnbaum was a co-founder and former Chief Medical Officer of Kythera Biopharmaceuticals (which was acquired by Allergan), and a member of the board of directors of Excaliard Pharmaceuticals (which was acquired by Pfizer). Dr. Birnbaum is a co-founder and member of the Board of Directors of Hallux, Inc., a co-founder and Executive Vice President of Lipido Pharmaceuticals, Inc., and serves on the scientific advisory board of several companies.
2023-07-27	Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies in his area of expertise. He previously served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals Corporation... Education: B.S. in Biology from Trinity College in Connecticut, Ph.D. in Pharmacology from the University of Wisconsin.
2024-07-01	Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies in his area of expertise... Education: B.S. in Biology from Trinity College in Connecticut, Ph.D. in Pharmacology from the University of Wisconsin.